Non-valvular atrial fibrillation - Globe Thesis

Keyword [Non-valvular atrial fibrillation] Result: 161 - 180 \| Page: 9 of 10
161.	Single-center Analysis Of The Current Status Of Anticoagulation Therapy And Influencing Factors In Patients With Non-valvular Atrial Fibrillation
162.	Changes And Clinical Significance Of T Lymphocyte Subsets And Cytokines In Blood Of Patients With Non-valvular
163.	Correlation Between Hyperuricemia And CHA₂DS₂-VASc Score In Patients With Nonvalvular Atrial Fibrillation
164.	The Study Of Correlation Between Activated T Cell Nuclear Factor 4 And Interleukin 6 Levels And Non-valvular Atrial Fibrillation
165.	Relationship Between Left Atrial Strain Measured By 4D Auto Left Atrial Quantitative Analysis And Embolism Risk In Patients With Non-valvular Atrial Fibrillation
166.	Risk Factors Analysis Of Patients With Non-valvular Atrial Fibrillation In Qinghai Area
167.	Incidence Of Left Atrial/left Atrial Appendage Thrombosis In Patients With Non Valvular Atrial Fibrillation And Its Anticoagulant Therapy Evaluation Of Efficacy And Safety:A Meta-analysis
168.	Relationship Between Total Bilirubin And Left Atrial Appendage Thrombus In Patients With Non-valvular Atrial Fibrillation
169.	Predictive Effect Of Monocyte To High-density Lipoprotein Ratio On Stroke In Patients With Nonvalvular Atrial Fibrillation
170.	Population Pharmacokinetics And Pharmacodynamics Of Rivaroxaban In Patients With Non-valvular Atrial Fibrillation
171.	The Effectiveness And Safety Of Low-dose Rivaroxaban In Elderly Patients With Non-valvular Atrial Fibrillation In Asia:A Meta-analysis
172.	Research Of Oral Anticoagulants In Patients With Non-valvular Atrial Fibrillation
173.	A Clinical Retrospective Study Of TCM Syndrome Factors And Medication Rules In Patients With Hypertension Complicated With Non-valvular Atrial Fibrillation
174.	Clinical Study On Between TCM Syndromes Of Non-valvular Atrial Fibrillation And CHA2DS2-VASc,Atrial Fibrillation Burden And Other Objective Indicators
175.	Risk Factors And Prediction Models For Late Recurrence Of Non-valvular Atrial Fibrillation After Catheter Ablation
176.	Exploration On Anticoagulant Therapy Of Warfarin And Rivaroxaban In Elderly Patients With Non-valvular Atrail Fibrillation
177.	Investigation On Anticoagulation Status Of Elderly Patients With Non-valvular Atrial Fibrillation In Secondary And Tertiary Hospitals Of Chongqing
178.	The Correlation Between Cystatin C,transforming Growth Actor ?1,carbohydrate Antigen 125 And Non-valvular Atrial Fibrillation
179.	Relationship Between Fibrinogen And Left Atrial Appendage Thrombogenic Milieu In Patients With Non-valvular Atrial Fibrillation
180.	Analysis Of Current Status Of Anticoagulant Therapy In Patients With Non-valvular Atrial Fibrillation
<<First <Prev Next> Last>> Jump to